Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Christopher Butler and Peter Barnes.
Christopher Butler
Connection Strength
0.119
Peter Barnes
  1. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021 09 04; 398(10303):843-855.
    View in: PubMed
    Score: 0.060
  2. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir Med. 2021 07; 9(7):763-772.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.